31 results on '"Michelson, Eric"'
Search Results
2. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
3. The evaluation and management of drug effects on cardiac conduction (PR and QRS Intervals) in clinical development
4. Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium
5. Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction
6. Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
7. Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme
8. Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme
9. Adherence to medication according to sex and age in the CHARM programme
10. Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program
11. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure
12. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
13. Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure—Assessment of Reduction in Mortality and morbidity programme
14. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme
15. The Hemoglobin A1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients With Chronic Heart Failure: An Analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
16. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
17. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
18. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
19. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial
20. Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker
21. Predictors of mortality and morbidity in patients with chronic heart failure
22. Impact of Candesartan on Nonfatal Myocardial Infarction and Cardiovascular Death in Patients With Heart Failure
23. Effect of candesartan on New York Heart Association functional class: Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
24. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors
25. Labetalol Hepatotoxicity
26. Histopathologic Correlates of Inducible Ventricular Tachycardia in Two Experimental Canine Models of Myocardial Infarction
27. Labetalol: An Alpha- and Beta-Adrenoceptor Blocking Drug
28. Canine Models for Ventricular Tachyarrhythmia
29. Nonsustained Ventricular Tachycardia in Ambulatory Patients: Characteristics and Association with Sudden Cardiac Death
30. Aspirin- and Coumadin®-Related Bleeding After Coronary-Artery Bypass Graft Surgery
31. Commentary 2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.